Evaluating Effectiveness and Long Term Safety of Damoctocog Alfa Pegol in Patients, Who Have Been Diagnosed With Hemophilia A
Clinical trial NCT03932201 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03932201
- Sponsor
- Bayer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2019-10-21
- Primary completion
- 2026-12-31
- Enrollment
- 371
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.